on Affluent Medical (isin : FR0013333077)
Carvolix: Update on capital and voting rights
Affluent Medical has announced updated figures regarding the share capital and voting rights of Carvolix. As of August 31, 2026, the company's share capital amounts to €6,227,517.70, representing a total of 62,275,177 shares. Theoretical voting rights total 90,262,800, while exercisable voting rights amount to 90,220,436. Theoretical voting rights include all shares, even those without voting rights, while exercisable voting rights do not.
The information was transmitted in accordance with the articles relating to the financial transparency of listed companies. Carvolix, with its innovations in medical technologies, continues its development in the field of heart disease.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Affluent Medical news